DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow DVA
DaVita Inc. (DVA) Return on equity
DaVita Inc.'s return on equity over the twelve months to 30 June 2026 was −287.3%, down 7033.5 percentage points from fiscal 2025 (6,746.2%). Over the past ten years it has ranged from 3.62% (fiscal 2018) to 6,746.2% (fiscal 2025) — the current reading is the highest in ten years. That is below the Medical Care Facilities industry median of 8.76% and below the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 6,746.2% | 6,632.00 |
| FY2024 | 114.2% | 48.95 |
| FY2023 | 65.2% | 3.39 |
| FY2022 | 61.9% | (16.34) |
| FY2021 | 78.2% | 38.37 |
| FY2020 | 39.8% | 13.78 |
| FY2019 | 26.0% | 22.42 |
| FY2018 | 3.62% | (10.01) |
| FY2017 | 13.6% | (4.08) |
| FY2016 | 17.7% | 12.54 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| CON Concentra Group Holdings Parent, Inc. compare | 47.7% |
| THC Tenet Healthcare Corporation compare | 37.3% |
| PACS PACS Group, Inc. compare | 27.9% |
| CHE Chemed Corporation compare | 27.1% |
| UHS Universal Health Services, Inc. compare | 20.8% |
| EHC Encompass Health Corporation compare | 19.3% |
| ENSG The Ensign Group, Inc. compare | 17.0% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 6.77% |
| DVA DaVita Inc. | −287.3% |
| Medical Care Facilities industry median | 8.76% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on DVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement